We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

132 hedge funds and large institutions have $1.53B invested in Intra-Cellular Therapies Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $1.11B → $1.53B (+$419M)

34% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 38

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

3% more funds holding

Funds holding: 128 → 132 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

65% less call options, than puts

Call options by funds: $5.66M | Put options by funds: $16.4M

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
26
Increased
51
Reduced
38
Closed
22
Calls
$5.66M
Puts
$16.4M
Net Calls
-$10.7M
Net Calls Change
-$15.4M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$43.2M
2
Millennium Management
Millennium Management
New York
+$22.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$22.1M
4
FCM
Frontier Capital Management
Massachusetts
+$15.6M
5
TCM
TimesSquare Capital Management
New York
+$11M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$18.8M
2
HCMT
Highland Capital Management (Texas)
Texas
-$17.4M
3
WA
Wasatch Advisors
Utah
-$14.9M
4
RCM
RA Capital Management
Massachusetts
-$12.6M
5
Morgan Stanley
Morgan Stanley
New York
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
51
Russell Frank Company
Washington
$3.33M -$23K -455 -0.7%
Ameriprise
52
Ameriprise
Minnesota
$3.27M +$926K +18,359 +43%
TA
53
Teachers Advisors
New York
$3.04M +$426K +8,450 +18%
AWCI
54
Alpine Woods Capital Investors
New York
$2.79M -$45.4K -900 -2%
HCMT
55
Highland Capital Management (Texas)
Texas
$2.78M -$17.4M -345,316 -87%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$2.66M +$497K +9,852 +25%
SFM
57
Sphera Funds Management
Israel
$2.6M -$2.88M -57,000 -54%
MCM
58
Moore Capital Management
New York
$2.42M +$2.27M +45,000 New
Renaissance Technologies
59
Renaissance Technologies
New York
$2.4M -$6.98M -138,391 -76%
HCM
60
Hodges Capital Management
Texas
$2.15M – – –
Swiss National Bank
61
Swiss National Bank
Switzerland
$2.15M – – –
OAM
62
Oxford Asset Management
United Kingdom
$1.99M +$1.85M +36,607 New
AQR Capital Management
63
AQR Capital Management
Connecticut
$1.98M -$281K -5,572 -13%
JP Morgan Chase
64
JP Morgan Chase
New York
$1.94M +$1.82M +36,128 New
FSA
65
Franklin Street Advisors
North Carolina
$1.75M -$36.6K -725 -2%
AllianceBernstein
66
AllianceBernstein
Tennessee
$1.68M – – –
SCM
67
Suffolk Capital Management
New York
$1.64M +$1.54M +30,505 New
CSS
68
Cubist Systematic Strategies
Connecticut
$1.59M +$942K +18,674 +172%
Goldman Sachs
69
Goldman Sachs
New York
$1.46M +$10.1K +200 +0.7%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$1.43M +$293K +5,800 +28%
Ohio Public Employees Retirement System (OPERS)
71
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.41M -$354K -7,025 -21%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$1.37M +$320K +6,345 +33%
TI
73
Turner Investments
Pennsylvania
$1.31M – – –
Citigroup
74
Citigroup
New York
$1.26M +$431K +8,539 +57%
Marshall Wace
75
Marshall Wace
United Kingdom
$1.25M +$222K +4,410 +24%
1 2
3
4 5

ITCI Hedge Fund Activity: Q4 2015 in Review

132 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q4 2015, worth a combined $1.53B — up 38% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ITCI positions and 22 closed out — a net gain of 4 holders — while 51 added to existing stakes and 38 trimmed.

The largest buyer was Jennison Associates, adding an estimated $43.2M. The largest seller was State Street, cutting an estimated $18.8M.

  • 132 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q4 2015, up from 128 in Q3 2015.
  • Funds reported $1.53B of Intra-Cellular Therapies Inc. stock for Q4 2015, up 38% quarter-over-quarter.
  • 26 funds opened new Intra-Cellular Therapies Inc. positions in Q4 2015 and 22 closed out, a net change of +4 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q4 2015 was Jennison Associates, an estimated $43.2M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q4 2015 was State Street, an estimated $18.8M sold.

Based on aggregated 13F filings for Q4 2015.